New research reveals that people who discontinue new GLP-1 drugs like Mounjaro or Wegovy may regain reduced body mass much more quickly than those who stop conventional lifestyle programs.
Published data in a leading medical journal points out that while obese people frequently drop substantial amounts of their total mass while using the jabs, the weight comes back at an average rate of 0.8 kg per month upon discontinuation.
"People purchasing these drugs should be informed of the risk of fast weight regain when the treatment ends," stated lead investigator Dr. Susan Jebb.
That rate of recovery means a return to original weight within about 18 months.
Analyzing Therapies
The research, which looked at dozens of studies involving over 9,000 of participants, compared the effects of the injectable medications with other pills.
Scientists emphasize that individuals who shed pounds through dieting generally have a less rapid creep back—approximately 100 grams monthly—once they finish.
Understanding the Quick Regain
Experts suggest the mechanism of the injections is key to understanding the heightened rebound.
GLP-1 drugs copy a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Long-term administration of the hormone concentrations several times higher than the body's typical production may cause the body to produce less of its own natural GLP-1, and may also reduce responsiveness to its effects," noted Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this GLP-1 'fix' results in hunger is unsuppressed, making binge eating much more probable."
A Lifelong Issue?
Medical guidelines recommend the jabs for people with obesity-related medical conditions, alongside recommended diet and exercise modifications.
Many experts contend that, due to the likelihood of weight regain, the therapy should be considered long-term.
This opinion is supported by drug manufacturers, who note that the findings "highlight the chronic character of obesity," akin to managing diseases like high blood pressure.
User Experiences
People who have come off the jabs explain a powerful resurgence of cravings.
"I experienced a switch that goes on and I was suddenly ravenous," said an individual.
The struggle is compounded if individuals have not established permanent lifestyle or habit modifications during treatment.
Significant Interest
Survey data show that a significant number of adults in the UK have tried weight-loss jabs in the past year, with interest remaining high.
- Adoption is higher among females compared to males.
- The middle-aged demographic shows the highest level of interest.
- A large proportion obtain the drugs through private healthcare rather than the NHS.
Ultimately, clinicians stress that while these medications are powerful tools for weight loss, they are not a magic cure and long-term success hinges on integrated behavioural changes.
